Liver International · Published 2022-07-01 · Available online 26 Mar 2022 · Journal article · DOI 10.1111/liv.15245 · Cited by 15 (Crossref)
David W. Matthews, Samantha Coleman, Homie Razavi, Jean‐Manuel Izaret
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Matthews, D., Coleman, S., Razavi, H., et al. (2022). The Payer License Agreement, or “Netflix model,” for hepatitis C virus therapies enables universal treatment access, lowers costs and incentivizes innovation and competition. Liver International. https://doi.org/10.1111/liv.15245